KYMRIAH⢠(tisagenlecleucel) | Official Site from Novartis
Meta Description
KYMRIAH⢠is a treatment option for pediatric patients with relapsed or refractory B-cell acute lymphoblastic leukemia. See full Prescribing & Safety Info, including Boxed Warning.
Meta Keywords
Technologies in use
Google Analytics, jQuery, jQuery UI, Modernizr, moment